. . . . . . . . . . . . . . . "TextLocation" . "Abstract" . "composite(a(SCHEM:\"SU 5416\"),a(SCHEM:\"SU 6668\")) -> bp(MESHPP:\"Cell Hypoxia\")" . "Approximately 2000 hand curated statements drawn from 57 PubMeds." . "Copyright (c) 2011-2012, Selventa. All Rights Reserved." . "BEL Framework Small Corpus Document" . "Creative Commons Attribution-Non-Commercial-ShareAlike 3.0 Unported License" . . "20131211" . "targeting VEGFR-2 plus the platelet- derived growth factor receptor (PDGFR)-β system\n(PDGFR- β) signaling (by SU6668) rapidly forced 40% of tumor blood vessels into\nregression, rendering these tumors hypoxic as shown by phosphorescence quenching." . . "support@belframework.org" . "Selventa" . . . . "2014-07-03T14:31:17.016+02:00"^^ . . .